Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Prattichizzo

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Cardiovascular Research|September 8, 2025
Microplastics and nanoplastics: tiny threats for cardiovascular diseases?Raffaele Marfella, Francesco Prattichizzo, Giuseppe Paolisso
Diabetologia|October 3, 2024
Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complicationsAntonio Ceriello, Francesco Prattichizzo, Cesare Berra
Metabolism: Clinical and Experimental|May 24, 2021
Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonistsFrancesco Prattichizzo, Paola de Candia, Antonio Ceriello
Diabetes Technology & Therapeutics|March 5, 2024
Obesity, NAFLD/NASH, and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
European Journal of Preventive Cardiology|November 15, 2019
The link between diabetes and atherosclerosisLucia La Sala, Francesco Prattichizzo, Antonio Ceriello
Diabetes, Obesity & Metabolism|May 29, 2020
Why is hyperglycaemia worsening COVID-19 and its prognosis?Antonio Ceriello, Valeria De Nigris, Francesco Prattichizzo
Nature Reviews. Endocrinology|November 10, 2019
Two drugs are better than one to start T2DM therapyFrancesco Prattichizzo, Lucia La Sala, Antonio Ceriello
Diabetes Technology & Therapeutics|March 17, 2025
Obesity and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
Diabetes Technology & Therapeutics|February 21, 2023
Obesity and DiabetesViral N Shah, Francesco Prattichizzo, Antonio Ceriello
Diabetes Technology & Therapeutics|March 9, 2026
Obesity and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Cardiovascular Research|September 8, 2025
Microplastics and nanoplastics: tiny threats for cardiovascular diseases?Raffaele Marfella, Francesco Prattichizzo, Giuseppe Paolisso
Diabetologia|October 3, 2024
Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complicationsAntonio Ceriello, Francesco Prattichizzo, Cesare Berra
Metabolism: Clinical and Experimental|May 24, 2021
Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonistsFrancesco Prattichizzo, Paola de Candia, Antonio Ceriello
Diabetes Technology & Therapeutics|March 5, 2024
Obesity, NAFLD/NASH, and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
European Journal of Preventive Cardiology|November 15, 2019
The link between diabetes and atherosclerosisLucia La Sala, Francesco Prattichizzo, Antonio Ceriello
Diabetes, Obesity & Metabolism|May 29, 2020
Why is hyperglycaemia worsening COVID-19 and its prognosis?Antonio Ceriello, Valeria De Nigris, Francesco Prattichizzo
Nature Reviews. Endocrinology|November 10, 2019
Two drugs are better than one to start T2DM therapyFrancesco Prattichizzo, Lucia La Sala, Antonio Ceriello
Diabetes Technology & Therapeutics|March 17, 2025
Obesity and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
Diabetes Technology & Therapeutics|February 21, 2023
Obesity and DiabetesViral N Shah, Francesco Prattichizzo, Antonio Ceriello
Diabetes Technology & Therapeutics|March 9, 2026
Obesity and DiabetesFrancesco Prattichizzo, Antonio Ceriello, Viral N Shah
Pageof 13